Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer.

Dalal, Kush; Roshan-Moniri, Mani; Sharma, Aishwariya; Li, Huifang; Ban, Fuqiang; Hassona, Mohamed D; Hsing, Michael; Singh, Kriti; LeBlanc, Eric; Dehm, Scott; Tomlinson Guns, Emma S; Cherkasov, Artem; Rennie, Paul S

Dalal, Kush; Roshan-Moniri, Mani; Sharma, Aishwariya; Li, Huifang; Ban, Fuqiang; Hassona, Mohamed D; Hsing, Michael; Singh, Kriti; LeBlanc, Eric; Dehm, Scott; Tomlinson Guns, Emma S; Cherkasov, Artem; Rennie, Paul S.

J Biol Chem ; 292(10): 4359, 2017 03 10.

Article in En | MEDLINE | ID: mdl-28283588

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354479
https://dx.doi.org/10.1074/jbc.A117.553818

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Biol Chem Year: 2017 Document type: Article

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354479
https://dx.doi.org/10.1074/jbc.A117.553818

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Biol Chem Year: 2017 Document type: Article